Iguchi et al. demonstrated that VEGF levels are significantly higher in HCC patients with bone metastasis compared to those without bone metastasis or only with chronic hepatitis/cirrhosis [28]. This evidence concerns the gene VEGFA and hepatocellular carcinoma.